Status:
COMPLETED
Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Myalgia
Bruxism
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Eighty individuals (44 female, 36 male), which were randomly divided into 4 groups of 20 patients each, due to the treatment type: Botulinum toxin (BTX); Dry needling (DN); Pharmacological therapy (PT...
Detailed Description
The study aimed to assess and compare the effectiveness of 4 different methods in the management bruxism: Botulinum toxin (BTX-A), dry needling (DN), pharmacological therapy (PT), and manual therapy (...
Eligibility Criteria
Inclusion
- Adult patients aged 18 to 65 years with complete dentition,
- Patients classified as American Society of Anesthesiologists (ASA) physical status ASA I or ASA II
- Patients experiencing moderate to severe pain in the masticatory muscles related to bruxism,
- Patients who had not previously been treated for bruxism
- Patients who were diagnosed with bruxism were excluded from the study.
Exclusion
- Presence of temporomandibular joint disorder
- Known allergy to botulinum toxin
- Pregnancy
- Presence of neuromuscular disease
- Chronic use of muscle relaxant medication within the last 3 months.
Key Trial Info
Start Date :
January 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06583551
Start Date
January 3 2021
End Date
September 1 2021
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences
Istanbul, Turkey (Türkiye)